PAC: FDA RFI
Return to Policy_Committee
FDA issued a File:PAC FDA NoM RfC.pdf. The comments are due October 5.
The 10 questions include a question on HL7 applicability, so it seems appropriate for HL7 to submit feedback to at least that question.
We wequest RCRIM and Pharmacy to provide input. Ed Tripp will coordinate.
- Ed created a draft document.
- This was reviewed by the Policy Committee off-line and accepted.
- Currently pending EC approval to be forwarded.